Scottish Liver Transplantation Unit, Royal Infirmary of Edinburgh, Little France, Edinburgh, UK.
Br J Clin Pharmacol. 2012 Feb;73(2):285-94. doi: 10.1111/j.1365-2125.2011.04067.x.
Paracetamol (acetaminophen) poisoning remains the major cause of severe acute hepatotoxicity in the UK. In this large single centre cohort study we examined the clinical impact of staggered overdoses and delayed presentation following paracetamol overdose.
Between 1992 and 2008, 663 patients were admitted with paracetamol-induced severe liver injury, of whom 161 (24.3%) had taken a staggered overdose. Staggered overdose patients were significantly older and more likely to abuse alcohol than single time point overdose patients. Relief of pain (58.2%) was the commonest rationale for repeated supratherapeutic ingestion. Despite lower total ingested paracetamol doses and lower admission serum alanine aminotransferase concentrations, staggered overdose patients were more likely to be encephalopathic on admission, require renal replacement therapy or mechanical ventilation and had higher mortality rates compared with single time point overdoses (37.3% vs. 27.8%, P= 0.025), although this overdose pattern did not independently predict death. The King's College poor prognostic criteria had reduced sensitivity (77.6, 95% CI 70.8, 81.5) for this pattern of overdose. Of the 396/450 (88.0%) single time point overdoses in whom accurate timings could be obtained, 178 (44.9%) presented to medical services >24 h following overdose. Delayed presentation beyond 24 h post overdose was independently associated with death/liver transplantation (OR 2.25, 95% CI 1.23, 4.12, P= 0.009).
Both delayed presentation and staggered overdose pattern are associated with adverse outcomes following paracetamol overdose. These patients are at increased risk of developing multi-organ failure and should be considered for early transfer to specialist liver centres.
对乙酰氨基酚(扑热息痛)中毒仍是英国严重急性肝毒性的主要原因。在这项大型单中心队列研究中,我们研究了扑热息痛过量服用后剂量间隔和延迟就诊对临床的影响。
1992 年至 2008 年间,663 例扑热息痛致严重肝损伤患者入院,其中 161 例(24.3%)为剂量间隔过量服用。剂量间隔过量服用者较单次过量服用者年龄更大,且更易酗酒。重复摄入超治疗剂量的常见原因是缓解疼痛(58.2%)。尽管总摄入对乙酰氨基酚剂量和入院时血清丙氨酸氨基转移酶浓度较低,但剂量间隔过量服用者入院时更可能出现脑病,需要肾脏替代治疗或机械通气,死亡率也高于单次过量服用者(37.3%比 27.8%,P=0.025),尽管这种过量模式并不能独立预测死亡。King 学院预后不良标准对这种剂量间隔模式的敏感性降低(77.6%,95%CI 70.8%,81.5%)。在 396/450(88.0%)例可准确获得时间的单次过量服用者中,178 例(44.9%)在过量服用后 24 小时以上就诊于医疗服务机构。超过 24 小时后就诊与死亡/肝移植独立相关(OR 2.25,95%CI 1.23,4.12,P=0.009)。
延迟就诊和剂量间隔模式均与扑热息痛过量服用后的不良结局相关。这些患者发生多器官衰竭的风险增加,应考虑尽早转至专科肝脏中心。